Search results
Results from the WOW.Com Content Network
The U.S. Supreme Court will only review cases on a discretionary basis and rarely decides patent cases. Unless overruled by a Supreme Court case, Federal Circuit decisions can dictate the results of both patent prosecution and litigation as they are universally binding on all United States district courts and the United States Patent and ...
On January 27, 2010, the court ordered the parties to address on the impact of these consolidated cases of the January 22, 2010 ruling by the International Trade Commission, as well as the status of any further proceedings in the ITC and the U.S. Patent and Trademark Office at the March 12, 2010 case management conference.
Concerning the issue of obviousness as applied to patent claims. Microsoft v. AT&T: 550 U.S. 437: 2007: Related to international enforceability of U.S. software patents. Quanta v. LG Electronics: 553 U.S. 617: 2008: Patent exhaustion and its applicability to certain types of method patents.
The Court then turned to the extent, if any, to which exhaustion of the patent rights on the microprocessor products exhausted patent rights relating to the combination products on which LGE had patents. In the Univis case the sale that exhausted patent rights was a sale of an unpatented semifinished lens blank, which subsequent processing ...
Apple's attorneys told the court the "ultimate purpose" of its lawsuit was not money, but to win an injunction against sales of Masimo's smartwatches after an infringement ruling.
Fonar was a dispute between medical device manufacturer Fonar Corporation and General Electric over Fonar's patent on MRI technology. Fonar's founder, Raymond Damadian, was issued U.S. Patent 3,789,832 (priority date 1972-03-17) [2] for an "apparatus and method for detecting cancer in tissue" using the magnetic resonance of atoms.
Alcatel-Lucent v. Microsoft Corp., also known as Lucent Technologies Inc. v. Gateway Inc., was a long-running patent infringement case between Alcatel-Lucent and Microsoft litigated in the United States District Court for the Southern District of California and appealed multiple times to the United States Court of Appeals for the Federal Circuit.
Bridge Medical, [8] the Federal Circuit Court of Appeals found inequitable conduct because a patent attorney failed to provide to patent examiners information from an office action in a related case. McKesson is a cautionary tale for patent applicants: be overly inclusive with patent submissions to ensure no omission will jeopardize a patent.